Search results

Applications, Recent results, Publications.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.  

ANSTO Publications Online is a digital repository for publications authored by ANSTO staff and collaborators since 1956.

On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.

On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

The final report on the safety of Building 23 by the independent expert review team has been completed.

See details of previously published customer updates from our Health products team. 

ANSTO can confirm it has completed its 9th successful export of spent fuel. The spent fuel, from OPAL, ANSTO’s multipurpose reactor, has gone to France for reprocessing.

The User Advisory Committee (UAC) is an independent group that provides advice to ANSTO Australian Synchrotron (AS) senior management on issues from a user perspective.

ANSTO is interested finding students to collaborate on Generation IV reactor systems.

ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.

Letter to Editor of the Sydney Morning Herald following publication of news report

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

The Australian Synchrotron provides funding support for successful beamtime applicants in the form of travel funding and/or onsite accommodation. Travel funds granted are to be used solely to cover the majority of the cost to travel to the AS facility. The User Office will book accommodation for interstate user groups at the onsite AS Guesthouse.